Syngulon is a synthetic biology startup developing original genetic technologies using bacteriocins to improve microbial fermentation.
Syngulon Solution is a low-cost, antibiotic-free selective innovation for increasing microbial fermentation.
Antibiotics are expected to be subject to zero-tolerance testing in the near future. Aside from the antibiotic itself, avoiding the usage of antibiotic resistance genes is obviously crucial because their full absence is the only method to prevent their spread in the environment or transfer of resistance to harmful bacteria.
Syngulon antibiotic-free selection method is based on the usage of bacteriocins, natural antibacterial peptides discovered in 1925 by Belgian scientist Andre Gratia.
Positive facts about Syngulon
- 100% reduction of antibiotic and antibiotic-resistance gene in the process and therefore in the environment – critical as Antimicrobial Resistance (AMR) is an increasingly serious threat to global public health
- At least 20% energy reduction due to increased efficiency of fermentation-based production
- At least 25% yield increase for use in pharma, cosmetics or enzyme production industries when produced by microbial fermentation
- Payback time of maximum 3 years
Visit their website for all details : https://syngulon.com/
More on this subject :
- 15 selected Apps & solutions for climate change
- Reimagining Our Waste: A New Approach for Improved Sustainability
- Sustainable Solutions for Taking on Climate Change
- Revolutionizing Sustainable Transport: A New Solution Emerges
- The Benefits of Eco-Friendly Living with a Sustainable Home
- The Future is Green: A Look at Environmental Sustainability
Help us driving the change on Instagram, Pinterest, Linkedin, Twitter or Medium.
